For this reason we have considered negative all CC/RC patients apparently showing the MET(13)–MET(15) fusion and not informative the NSCLC patient showing the FGFR3(17)–TACC3(11) fusion. This evidence concerns the gene FGFR3 and non-small cell lung carcinoma.